Micromet Announces Pricing of Public Offering of Co... (clinical trial conducted by Micromet's c...)

Micromet Announces Pricing of Public Offering of Common Stock

Date:7/30/2009

clinical trial conducted by Micromet's collaboration partner Nycomed. Micromet's licensee Morphotek, a wholly-owned subsidiary of Eisai, is also expected to initiate a phase 1 clinical trial in 2009 with Micromet's glycolipid-binding human antibody MT228 for the treatment of melanoma.

Micromet's preclinical product pipeline includes several novel BiTE antibodies generated with its proprietary BiTE antibody platform technology. A BiTE antibody targeting CEA for the treatment of solid tumors is being developed in collaboration with MedImmune. In addition, Micromet has entered into an option, collaboration and license agreement with Bayer Schering Pharma AG under which Bayer Schering Pharma was granted an exclusive option until January 2010 to license a specified BiTE antibody against an undisclosed solid tumor target. Other BiTE antibodies targeting MSCP, CD33, HER2, EGFR and other targets are in various stages of preclinical development.

Forward-Looking Statements

This release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. These forward-looking statements include statements regarding the efficacy, safety and intended utilization of our product candidates, the conduct, timing and results of future clinical trials, and expectations of the future expansion of our product pipeline and collaborations. You are urged to consider statements that include the words "ongoing," "may," "will," "believes," "potential," "expects," "plans," "anticipates," "intends," or the negative of those words or other similar words to be uncertain and forward-looking. Factors that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include the risk that product candida
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
2. Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
3. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
4. Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference
5. Micromet to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007
6. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
7. Micromet to Present at the 2007 RBC Capital Markets Healthcare Conference on December 12, 2007
8. Micromet to Present at Two Upcoming Investor Conferences
9. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
10. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
11. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results

Post Your Comments:

(Date:5/23/2013)... 2013 Ralph Huber, President of PHI ... management products and emergency survival kits would be on ... made at the quarterly executive board meeting on May 22nd. ... silence for the Oklahoma tornado victims and used the opportunity ... their emergency kits is paramount. “When disaster strikes,” he ...

(Date:5/22/2013)... Cambridge Semantics was one of just ... Day” on Capitol Hill, hosted by The Data ... others to showcase how innovative data management applications can address ... (DATA Act). , Originally introduced in 2011 by Committee ... Mark Warner (D-VA ), the DATA Act is ...

(Date:5/22/2013)... CANTON, Mass. and NEW ORLEANS ... commercial leader in the field of regenerative medicine, presented ... expert economists from Analysis Group (a leading health economics ... that diabetic foot ulcers (DFU) and venous leg ulcers ... The results of this research, which reveal annual ...

(Date:5/22/2013)... Earth, MN (PRWEB) May 22, 2013 ... Royal Medical Supplies Pty Ltd are pleased to ... Medical is the Australian and New Zealand distributor of ... Motorsport V8 Supercar Team participated in the Austin 400 ... has entered into an agreement that involves each car ...

Breaking Biology Technology:PHI Emergency Management on Announces Father's Day Specials All Emergency Survival Kits 2 Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill 2 Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2 Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3 Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4 Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2

[0] PHI Emergency Management on Announces Father's Day Specials All Emergency Survival Kits [0] Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill [0] Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers [0] Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team

... facility to support clinical development for ... lead drug candidate and other molecules, ... radiopharmaceutical company that designs, develops and,manufactures products to detect, ... completed commissioning its in-house manufacturing,capability to meet clinical trial ...

... (OTC Bulletin Board: YGYB) ("Yongye" or the "Company"),a leading ... in the People,s Republic of China, today announced its ... Second Quarter 2008 Highlights -- Revenue was ... quarter of 2007, and an ...

... 15 The backpack is a back-to-school,staple. In ... fashion accessory as,well. However, backpacks are a leading ... children and adolescents. As students head back to ... preventing,unnecessary backpack pain and injuries., The MCA ...

Cellectar, Inc. Begins GMP Production Yongye Biotechnology International Announces Second Quarter Results Minnesota Chiropractic Association Offers Backpack Safety Checklist

(Date:5/22/2013)... Declines in the biodiversity of pollinating insects and wild ... new study. , Researchers led by the University of ... found evidence of dramatic reductions in the diversity ... the 1950s and 1980s. , But the picture brightened ... national biodiversity losses among bees, hoverflies and wild plants. ...

(Date:5/21/2013)... A new analysis shows that the nation,s land ... enough algae to produce up to 25 billion gallons ... one-twelfth of the country,s yearly needs. , The findings ... that would be needed to grow significant amounts of ... were published in the May 7 issue of ...

(Date:5/21/2013)... Water Center today awarded 12 research grants, totaling ... protection efforts. , The two-year grants of up ... to track the remediation of harmful algae blooms; ... weedy plant invasions; study chromosomal damage in tree ... activities. , The grants were awarded to multidisciplinary ...

Breaking Biology News(10 mins):Encouraging signs for bee biodiversity 2 Encouraging signs for bee biodiversity 3 Going green: Nation equipped to grow serious amounts of pond scum for fuel 2 Going green: Nation equipped to grow serious amounts of pond scum for fuel 3 Going green: Nation equipped to grow serious amounts of pond scum for fuel 4 U-M Water Center awards $570K in Great Lakes restoration grants 2 U-M Water Center awards $570K in Great Lakes restoration grants 3 U-M Water Center awards $570K in Great Lakes restoration grants 4

[0] Encouraging signs for bee biodiversity [0] Going green: Nation equipped to grow serious amounts of pond scum for fuel [0] U-M Water Center awards $570K in Great Lakes restoration grants

... A University of Minnesota Medical School research team ... offer a novel approach to ease the chronic and ... Using a mouse model of SCD, Gupta and University ... animals that exhibited both musculoskeletal pain and temperature sensitivity, ...

... EAST LANSING, Mich. A Michigan State University researcher ... parkin may help nerve cells fight off damage from ... therapies for the degenerative ailment. John Goudreau, an ... Unit, believes parkin can rescue certain neurons from injury ...

... a broad effort to achieve breakthrough innovations in energy production, ... award of up to $122 million over five years to ... Innovation Hub aimed at developing revolutionary methods to generate fuels ... Artificial Photosynthesis (JCAP), to be led by the California Institute ...

Cached Biology News:UM researcher identifies novel treatment for pain in sickle cell disease 2 Specific protein may help neurons fix themselves in Parkinson's patients 2 California team to receive up to $122 million to develop method to produce fuels from sunlight 2 California team to receive up to $122 million to develop method to produce fuels from sunlight 3

UM researcher identifies novel treatment for pain in sickle cell disease Specific protein may help neurons fix themselves in Parkinson's patients California team to receive up to $122 million to develop method to produce fuels from sunlight

... Adept CE 4100 high pressure pump ... precision, with software drive compensation, reducing pulsing ... are selectable in 0.001mL steps. , The ... and bio-compatible., Pumps may be programmed from ...

High affinity antibodies recognizes HSP70 protein from human cardiac tissue. Could be used for Westerb blotting application, ELISA....

Recommended for use as a cell culture substratum at 0.1-0.2 mg/cm 2 or 5-10 μl/cm 2 . Optimal concentration depends on cell type as well as the application or research objectives. Type B...

Monoclonal antibodies conjugated with rhodamine...

Biology Products:

High Pressure Dual Piston Analytical Pump from Cecil Instruments Ltd.Anti-Human Heat Shock Protein 70, Cardiac Tissue (HSP 70) Monoclonal Antibody, Unconjugated from HyTest Ltd.Gelatin from bovine skin from Sigma-Aldrich Mouse Anti-Fatty Acid Binding Protein (FABP) Antibody, TRITC (Rhodamine) Conjugated from HyTest Ltd.